These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Testis cancer markers. Clinical use]. Author: Salesi N, Di Cocco B, Alghisi F, Calabretta F, Bossone G. Journal: Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169. Abstract: Testis tumour is relatively rare and more frequent between 15-35 years of age. The 90% of this tumour derivates from germinal cells, the remaining cases originate from stromal cells or are secondary lesions from other neoplasms. The present clinical use of serum markers, especially alfa-fetoprotein (AFP), human chorionic gonadotrophin protein (HCG) and serum lactate dehydrogenase (LDH) is examined.[Abstract] [Full Text] [Related] [New Search]